How to improve payer engagement with tailored value communicationPharmaceutical drug success rests on being able to achieve market access. Brands are facing increasing pressure to demonstrate Share XHow to improve payer engagement with tailored value communicationhttps://deep-dive.pharmaphorum.com/magazine/market-access-2021/how-to-improve-payer-engagement-with-tailored-value-communication/
3 practical steps for improving patient supportResearch Partnership’s Emilie Braund and Harrison Gaiger dig down into the top insights pharma companies can harness to Share X3 practical steps for improving patient supporthttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/practical-steps-for-improving-patient-support/
3 innovations booming during COVID-19Research Partnership’s Vicki Newlove explores research into digital change during COVID-19 to find out what business questions pharma Share X3 innovations booming during COVID-19https://deep-dive.pharmaphorum.com/magazine/digital-health-innovation-2020/3-innovations-booming-during-covid-and-how-to-adopt-them-successfully/
Breaking policy and perceptual barriers: BiosimilarsExperts from Research Partnership analyse the company’s Therapy Watch data to identify how market access policy has impacted Share XBreaking policy and perceptual barriers: Biosimilarshttps://deep-dive.pharmaphorum.com/magazine/market-access-2020/breaking-policy-and-perceptual-barriers-biosimilars/
The promise and pitfalls of molecular testing in oncologyGreat strides have been made in the diagnosis and treatment of cancer. However, a variety of challenges remain Share XThe promise and pitfalls of molecular testing in oncologyhttps://deep-dive.pharmaphorum.com/magazine/oncology-asco-2019/research-partnership-molecular-testing-cancer/
China in the fast laneBrett Gardiner and Boon Yap from Research Partnership discuss access opportunities for novel therapies in the world’s hottest Share XChina in the fast lanehttps://deep-dive.pharmaphorum.com/magazine/access-and-commercialisation/research-partnership-pharma-market-access-china/
Deep Dive: Access and CommercialisationIn this issue of Deep Dive we explore the ever present issues of market access and commercialisation, analysing Share XDeep Dive: Access and Commercialisationhttps://pharmaphorum.com/digital/pharma-access-commercialisation/
Navigating new frontiers: Ways to find space in the future RA marketOverview Rheumatoid arthritis (RA) has been a major growth driver for the pharmaceutical industry over the last 15 Share XNavigating new frontiers: Ways to find space in the future RA markethttps://pharmaphorum.com/r-d/navigating-new-frontiers-ways-to-find-space-in-the-future-ra-market/
Are dual ARVs the new frontier in a maturing HIV market?Tackling and managing HIV has been one of the pharmaceutical industry’s more distinguished achievements, despite the turbulence and Share XAre dual ARVs the new frontier in a maturing HIV market?https://pharmaphorum.com/sales-marketing/are-dual-arvs-the-new-frontier-in-a-maturing-hiv-market/
